截至月份: 2025年11月30日 狀態: 新提交 FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 致：香港交易及結算所有限公司 公司名稱: 北大資源(控股)有限公司（於百慕達註冊成立之有限公司） 呈交日期: 2025年12月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00618 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 150,000,000,000 | HKD | | 0.01 HKD | | 1,500,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | 本月底結存 | | | 150,000,000,000 | HKD | | 0.01 HKD | | 1,500,000 ...

Group 1 - As of December 1, 46 stocks reached a 52-week high, with the top three being Financial Media (00205), Beijing Resources (00618), and Yiyuan Wine Industry (08146), achieving high rates of 46.39%, 35.42%, and 33.33% respectively [1] - Financial Media closed at 0.680, with a peak price of 0.710, marking a 46.39% increase [1] - Beijing Resources closed at 0.233, reaching a high of 0.325, reflecting a 35.42% increase [1] - Yiyuan Wine Industry closed at 0.275, with a maximum price of 0.340, indicating a 33.33% increase [1] Group 2 - The 52-week low rankings included Baofa Holdings (08532) with a closing price of 0.013, showing a decrease of 27.78% [2] - Tianhou Cultural (08500) closed at 0.165, with a low of 0.141, reflecting a decline of 22.53% [2] - Ziyuan Yuan (08223) reached a low of 0.475, closing at 0.480, indicating a decrease of 13.64% [2]

Core Viewpoint - North China Resources (00618.HK) experienced a significant increase in stock price, rising over 32% in the afternoon trading session, indicating strong market interest and potential investor confidence [2] Company Summary - The stock price of North China Resources reached 0.242 HKD, reflecting a gain of 32.24% [2] - The trading volume amounted to 2.5709 million HKD, suggesting active trading and interest in the stock [2]

Core Viewpoint - Beijing Resources (00618) experienced a significant stock price increase of over 32%, reaching HKD 0.242, with a trading volume of HKD 2.5709 million following the release of its interim results for the six months ending September 30, 2025 [1] Financial Performance - The company reported revenue of RMB 807 million, reflecting a year-on-year growth of 8.05% [1] - Profit attributable to shareholders turned positive at RMB 1.875 billion, compared to a loss in the previous period [1] - Basic earnings per share were reported at 68.50 cents [1] Revenue Drivers - The increase in revenue was primarily driven by the e-commerce and distribution business, which contributed approximately RMB 116 million due to the addition of new e-commerce platforms and product lines [1] - There was a slight increase in revenue from property investment and management, amounting to approximately RMB 3.476 million [1]

Core Viewpoint - Beijing Resources (00618) experienced a significant stock price increase of over 32% following the release of its interim results for the six months ending September 30, 2025, indicating strong financial performance and recovery from previous losses [1] Financial Performance - The company reported revenue of 807 million yuan, representing a year-on-year growth of 8.05% [1] - Profit attributable to shareholders was 1.875 billion yuan, marking a turnaround from previous losses [1] - Basic earnings per share were reported at 68.50 cents [1] Revenue Drivers - The increase in revenue was primarily driven by the e-commerce and distribution business, which contributed an additional 116 million yuan due to new e-commerce platforms and product lines [1] - There was a slight increase in revenue from property investment and management, amounting to approximately 3.476 million yuan [1]

Core Viewpoint - North China Resources (00618) experienced a significant stock price increase of over 32% following the release of its interim results for the six months ending September 30, 2025, indicating strong financial performance and recovery from previous losses [1] Financial Performance - The company reported revenue of 807 million yuan, representing a year-on-year growth of 8.05% [1] - Net profit attributable to shareholders was 1.875 billion yuan, marking a turnaround from previous losses [1] - Basic earnings per share were reported at 68.50 cents [1] Revenue Drivers - The increase in revenue was primarily driven by the e-commerce and distribution business, which contributed an additional 116 million yuan due to new e-commerce platforms and product lines [1] - There was a slight increase in revenue from property investment and management, amounting to approximately 3.476 million yuan [1]

Core Viewpoint - North China Resources (00618) reported a revenue of 807 million yuan for the six months ending September 30, 2025, representing a year-on-year increase of 8.05% [1] Financial Performance - The company achieved a profit attributable to shareholders of 1.875 billion yuan, marking a turnaround from a loss in the previous period [1] - Basic earnings per share were reported at 68.50 cents [1] Revenue Drivers - The increase in revenue was primarily driven by the e-commerce and distribution business, which contributed an additional 116 million yuan due to new e-commerce platforms and product lines [1] - There was a slight increase in revenue from property investment and management, amounting to approximately 3.476 million yuan [1]

Core Insights - The company reported a revenue of 807 million RMB for the six months ending September 30, 2025, representing a year-on-year growth of 8.05% [1] - The profit attributable to the company's owners was 1.875 billion RMB, marking a turnaround from a loss to profit compared to the previous year [1] - Basic earnings per share were reported at 0.685 RMB [1] Revenue Breakdown - The increase in revenue was primarily driven by the e-commerce and distribution business, which contributed an additional 116 million RMB due to new e-commerce platforms and product lines [1] - The property investment and management business saw a slight revenue increase of approximately 3.476 million RMB [1]

Core Viewpoint - The company reported a significant recovery in financial performance, with a notable increase in revenue and a shift from loss to profit in the latest reporting period [1] Financial Performance - The group's revenue for the six months ending September 30, 2025, increased by 8.05% to approximately RMB 807 million [1] - The group reported a profit of approximately RMB 1.883 billion, compared to a loss of approximately RMB 1.35 billion for the same period ending September 30, 2024 [1] - Earnings per share attributable to the company's owners were RMB 0.685 [1] Business Operations - The company operates the well-known "Ye Kai Tai" brand in the retail pharmacy sector within China [1] - The company is enhancing its "pharmacy + traditional Chinese medicine" store operation model, focusing on the integration of pharmaceutical retail and medical services [1] - A new traditional Chinese medicine clinic and retail pharmacy complex was opened in Wuhan [1] - The company is optimizing the operational efficiency and profitability of existing stores, leading to the closure of some underperforming locations [1] - As of September 2025, the company operates 40 retail pharmacies, 14 traditional Chinese medicine clinics, 2 dermatology clinics, and an online pharmacy [1] - The company is increasing investment in online business resources, fully developing its pharmaceutical e-commerce (B2C) and O2O instant delivery business segments [1]

Financial Performance - Revenue for the six months ended September 30, 2025, was RMB 806,579,000, an increase from RMB 746,509,000 for the same period in 2024, representing a growth of approximately 8%[3] - Gross profit for the same period was RMB 73,727,000, compared to RMB 19,516,000 in 2024, indicating a significant improvement[3] - Net profit for the six months ended September 30, 2025, was RMB 1,883,489,000, a turnaround from a loss of RMB 1,354,773,000 in 2024[4] - Basic and diluted earnings per share for the period were RMB 68.50, compared to a loss of RMB 46.80 per share in the previous year[4] - Other income and gains for the period amounted to RMB 2,302,859,000, up from RMB 299,156,000 in 2024[3] - Total comprehensive income for the six months was RMB 1,994,817,000, compared to a loss of RMB 1,321,453,000 in the same period last year[5] Cost Management - The company reported a decrease in administrative and other operating expenses to RMB 81,286,000 from RMB 115,351,000 in the previous year, reflecting improved cost management[3] - Financial expenses decreased to RMB 69,997,000 from RMB 85,447,000, indicating better financial efficiency[3] Asset and Liability Management - As of September 30, 2025, total non-current assets amounted to RMB 1,933,304,000, an increase from RMB 1,639,690,000 as of March 31, 2025, reflecting a growth of approximately 18%[6] - Current assets totaled RMB 8,279,542,000, significantly higher than RMB 3,327,474,000 reported on March 31, 2025, indicating a growth of over 148%[6] - Total liabilities reached RMB 9,409,989,000, compared to RMB 2,576,524,000 in the previous period, marking an increase of approximately 265%[6] - The company's net asset value was reported at RMB 2,067,698,000, a substantial increase from RMB 397,102,000 as of March 31, 2025[7] Business Segments Performance - The medical and pharmaceutical retail segment generated revenue of RMB 70,714 thousand, a decrease of 1.2% from RMB 72,615 thousand in the previous year[17] - The e-commerce and distribution segment reported revenue of RMB 427,727 thousand, an increase of 37% from RMB 312,047 thousand in the prior period[17] - The property investment and management segment achieved revenue of RMB 2,533,709 thousand, significantly up from RMB 590,281 thousand, marking an increase of approximately 329%[17] Strategic Initiatives - The company plans to continue expanding its market presence and investing in new product development to sustain growth[2] - The company is focusing on expanding its e-commerce capabilities and enhancing its product offerings in the medical retail sector[15] - Future outlook includes continued investment in property development and management to leverage market opportunities[15] - The company is exploring potential mergers and acquisitions to enhance its market position and expand its operational footprint[15] Shareholder Value and Equity - The total equity attributable to the owners of the company was RMB 734,787,000, a significant recovery from a loss of RMB 1,256,206,000 in the previous period[7] - The company reported a net profit attributable to shareholders of RMB 1,875,231 thousand for the six months ended September 30, 2025, compared to a loss of RMB (1,265,687) thousand for the same period in 2024[40] - Basic and diluted earnings per share attributable to shareholders were RMB 0.685, compared to a loss of RMB 0.468 for the same period last year[78] Market Trends and Economic Environment - In the first three quarters of 2025, China's GDP reached RMB 97.1 trillion, growing by 5.2% year-on-year[57] - The total retail sales of consumer goods in China amounted to RMB 36.6 trillion, with a year-on-year increase of 4.5%[57] - Online retail sales exceeded RMB 11.3 trillion, representing a year-on-year growth of 9.8%, which is approximately double the overall consumption market growth rate[61] Corporate Governance and Compliance - The company is committed to maintaining high corporate governance standards and has adhered to all corporate governance code provisions during the reporting period[126] - The audit committee has reviewed the accounting policies and interim financial statements for the six months ending September 30, 2025[127] Share Option Plan - The 2023 Share Option Plan allows for the issuance of up to 10% of the total shares issued as of the adoption date, equating to 912,966,911 shares[50] - A total of 600,000,000 share options were granted to employees under the 2023 Share Option Plan, allowing for the subscription of 600,000,000 shares[51] - The exercise price for the share options is set at HKD 0.101 per share, subject to adjustment due to a capital reorganization[52]